Ivor Elrifi
Patrimonio netto: 5 M $ in data 31/08/2026
Patrimonio netto: 5 M $ in data 31/08/2026
Ivor Elrifi is Chief Executive Officer & Executive Director at Tiziana Life Sciences Ltd. since 2024.
Formerly, Dr. Elrifi was Global Head-Patent at Cooley LLP from 2014 to 2024 and Global Head-Patents at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC from 1999 to 2014.
Education includes undergraduate and doctorate degrees from Queen's University and a graduate degree from Osgoode Hall Law School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/08/2026 | 4.793.684 ( 3,74% ) | 5 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Amministratore Delegato | 19/08/2024 |
| Società | Posizione | Fine |
|---|---|---|
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/08/2024 |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Osgoode Hall Law School
Osgoode Hall Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale